Related Experiment Video
Updated: Jul 15, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Infants born to narcotic dependent mothers: physical growth patterns in the first 12 months of life
J C Vance1, D C Chant, D I Tudehope
1Department of Paediatrics and Child Health, Mater Children's Hospital, South Brisbane, Australia.
Insights
Infants born to narcotic-dependent mothers show intrauterine growth retardation at birth. By 12 months, their growth catches up, but may still be influenced by maternal drug use during pregnancy.
Area of Science:
- Neonatal development
- Pediatric growth studies
- Maternal substance use impact
Background:
- Infants born to narcotic-dependent mothers (INDM) face unique developmental challenges.
- Understanding their physical growth is crucial for early intervention.
Purpose of the Study:
- To track the physical growth of INDM over their first year.
- To investigate the correlation between maternal drug use patterns and infant growth.
Main Methods:
- A cohort of 43 INDM was monitored for 12 months.
- Weight and length were measured and converted to Z scores.
- Maternal drug use, demographics, and neonatal withdrawal were assessed via questionnaires.
Main Results:
- 55.8% of INDM experienced neonatal drug withdrawal requiring treatment.
- Infants exhibited intrauterine growth retardation at birth (low Z scores).
- Catch-up growth occurred by 12 months, though Z scores remained below zero; higher maternal methadone dosage correlated with persistent weight retardation.
Conclusions:
- INDM show initial intrauterine growth retardation, with growth approaching community norms by 12 months.
- Maternal narcotic use during pregnancy appears to influence infant growth patterns.
- Further research can clarify the long-term effects and optimal support strategies.
Objectives:
To describe the physical growth patterns of infants born to narcotic dependent mothers (INDM) over a 12 months period and, if possible, to relate the growth to drug taking patterns during pregnancy.
Methodology:
The growth of a cohort of 43 INDM was measured during the first 12 months of life. Weight and length measurements were compared with percentile charts and converted to Z scores. Questionnaire data about drug taking practices, demographic variables and the neonatal period (including withdrawal scores) were obtained.
Results:
Twenty-four (55.8%) of INDM had evidence of neonatal drug withdrawal requiring treatment with phenobarbitone. At birth, Z scores for weight and length indicated relative intrauterine growth retardation. By 12 months, there had been some catch up growth, but Z scores for weight and length were still below zero. Persistent weight retardation at 12 months was correlated with methadone dosage during pregnancy, but not the need for phenobarbitone therapy.
Conclusions:
The growth patterns of INDM in the first 12 months of life indicated that at birth there was evidence of intrauterine growth retardation, but by 12 months the growth was little different from the rest of the community. There appears to be some influence of narcotic agents taken while pregnant on subsequent growth of INDM.
More Related Videos
Related Concept Videos
Nature and Nurture
Factors Affecting Drug Response: Overview
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism

